Liang; Bailin

Patent Applications and Registrations

Patent applications and USPTO patent grants for Liang; Bailin.The latest application filed is for "anti-il-6 antibody".

Company Profile

3.14.18

Liang; Bailin - Jacksonville FL
Liang; Bailin - Shenzhen CN
Liang; Bailin - Jacksonfille FL
Liang; Bailin - Gilbertsville PA US

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Anti-IL-6 Antibody App 20220048985 - Chen; Yan ; et al.	2022-02-17
Methods of suppressing rheumatoid arthritis using an anti-IL-6 antibody Grant 11,180,549 - Chen , et al. November 23, 2	2021-11-23
Self-deploying Tree System App 20210113007 - Ocegueda Gallaga; Victor Hugo ; et al.	2021-04-22
Self-deploying tree system Grant 10,874,241 - Gallaga , et al. December 29, 2	2020-12-29
Methods of Suppressing Rheumatoid Arthritis Using an Anti-IL-6 Antibody App 20200115445 - Chen; Yan ; et al.	2020-04-16
Self-deploying Tree System App 20180028009 - Ocegueda Gallaga; Victor Hugo ; et al.	2018-02-01
Methods of Suppressing Rheumatoid Arthritis Using An Anti-IL-6 Antibody App 20170253651 - Chen; Yan ; et al.	2017-09-07
Pen-injector device containing anti-IL-6 antibodies Grant 9,631,016 - Chen , et al. April 25, 2	2017-04-25
Anti-IL-6 Antibodies, Compositions, Methods and Uses App 20160222104 - Chen; Yan ; et al.	2016-08-04
Anti-IL-6 antibodies, compositions, methods and uses Grant 9,340,613 - Chen , et al. May 17, 2	2016-05-17
Anti-IL-6 Antibodies, Compositions, Methods and Uses App 20140099311 - Chen; Yan ; et al.	2014-04-10
Anti-IL-6 antibodies Grant 8,623,362 - Chen , et al. January 7, 2	2014-01-07
Anti-IL-6 Antibodies, Compositions, Methods and Uses App 20130017208 - Chen; Yan ; et al.	2013-01-17
CXCL13 antagonists and their use for the treatment of inflammatory diseases Grant 8,277,809 - Bugelski , et al. October 2, 2	2012-10-02
Anti-IL-6 antibodies, compositions, methods and uses Grant RE43,672 - Chan , et al. September 18, 2	2012-09-18
Anti-IL-6 antibodies, compositions, methods and uses Grant 8,226,611 - Chen , et al. July 24, 2	2012-07-24
Anti-IL-6 Antibodies, Compositions, Methods and Uses App 20120045453 - CHEN; YAN ; et al.	2012-02-23
Methods of treating conditions using anti-IL-6 antibodies Grant 8,067,003 - Chen , et al. November 29, 2	2011-11-29
Methods of Diagnosing and Treating Conditions Using Anti-IL-6 Antibodies App 20110081355 - CHEN; YAN ; et al.	2011-04-07
Anti-IL-6 antibody nucleic acid molecules and methods Grant 7,833,755 - Chen , et al. November 16, 2	2010-11-16
Anti-IL-6 Antibody Nucleic Acid Molecules and Methods App 20090239258 - Chen; Yan ; et al.	2009-09-24
Anti-il-6 antibodies, compositions, methods and uses Grant 7,560,112 - Chen , et al. July 14, 2	2009-07-14
CXCL13 Antagonists and Their Use for the Treatment of Inflammatory Diseases App 20090136512 - Bugelski; Peter ; et al.	2009-05-28
CNGH0010 Specific Polynucleotides, Polypeptides, Antibodies, Compositions, Methods and Uses App 20090137783 - Song; Xiao-yu R. ; et al.	2009-05-28
CNGH0010 specific polynucleotides, polypeptides, antibodies, compositions, methods and uses Grant 7,479,479 - Song , et al. January 20, 2	2009-01-20
CNGH0010 Specific Polynucleotides, Polypeptides, Antibodies, Compositions, Methods and Uses App 20080044422 - Song; Xiao-yu R. ; et al.	2008-02-21
CNGH0010 specific polynucleotides, polypeptides, antibodies, compositions, methods and uses Grant 7,326,687 - Song , et al. February 5, 2	2008-02-05
CXCL13 Antagonists and Their Use for the Treatment of Inflammatory Diseases App 20080014201 - Bugelski; Peter ; et al.	2008-01-17
Anti-IL-6 antibodies, compositions, methods and uses App 20060257407 - Chen; Yan ; et al.	2006-11-16
CNGH0010 specific polynucleotides, polypeptides, antibodies, compositions, methods and uses App 20060141479 - Song; Xiao-Yu ; et al.	2006-06-29

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.